0001209191-14-036356.txt : 20140522 0001209191-14-036356.hdr.sgml : 20140522 20140522182820 ACCESSION NUMBER: 0001209191-14-036356 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140521 FILED AS OF DATE: 20140522 DATE AS OF CHANGE: 20140522 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LA JOLLA PHARMACEUTICAL CO CENTRAL INDEX KEY: 0000920465 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330361285 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4660 LA JOLLA VILLAGE DRIVE, SUITE 1070 CITY: SAN DIEGO STATE: CA ZIP: 92122 BUSINESS PHONE: 858-207-4264 MAIL ADDRESS: STREET 1: 4660 LA JOLLA VILLAGE DRIVE, SUITE 1070 CITY: SAN DIEGO STATE: CA ZIP: 92122 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: TIDMARSH GEORGE F CENTRAL INDEX KEY: 0001287235 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36282 FILM NUMBER: 14864973 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2014-05-21 0 0000920465 LA JOLLA PHARMACEUTICAL CO LJPC 0001287235 TIDMARSH GEORGE F C/O LA JOLLA PHARMACEUTICAL COMPANY, 4660 LA JOLLA VILLAGE DRIVE, SUITE 1070 SAN DIEGO CA 92122 1 1 1 0 President, CEO & Secretary Common Stock 2014-05-21 4 P 0 12000 7.37 A 20000 I By children Common Stock 1391086 D Represents the weighted-average price at which shares were purchased within a range between $7.259 and $7.669. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. /s/ Ryan Murr, as attorney-in-fact for George F. Tidmarsh 2014-05-22